The program is designed to treat complex tumor-multiplying diseases, such as neurofibromatosis 2, schwannomatosis tuberous sclerosis, von Hippel-Lindau disease, Sturge Weber syndrome and hemorrhagic telangiectasia. These disorders are rare and often have no cure.
The program includes a multidisciplinary team that provides ongoing surveillance and coordination of all treatments and check-ups.
More Articles on Hospital Oncology:
Commonwealth Cancer Centers of Kentucky Joins UK Markey Cancer Center Network
Pacific Cancer Institute of Maui to Begin $7M Expansion
Mayo Clinic Names Coborn Cancer Center First Member of New Cancer Care Network
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
